(VVUS) |
0 (0%) 10-10 23:48 |
Open: | |
High: | |
Low: | |
Volume: | 0 |
Market Cap: | 0(M) |
PE Ratio: | 0 |
Exchange: | |
Industry: | |
Sector: |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 0.43 |
Resistance 1: | 0.30 |
Pivot price: | 0.20 |
Support 1: | 0.10 |
Support 2: | 0.08 |
52w High: | |
52w Low: |
EPS | 0.000 |
Book Value | 0.000 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | 0.00 |
Return on Assets (ttm) | 0.0 |
Return on Equity (ttm) | 0.0 |
Mon, 26 Sep 2022
Vertex Ventures US Raises $200 Million Third Fund to Double-down on high-conviction approach to venture capital - Business Wire
Thu, 18 Sep 2014
Drug Stock Goes Bananas After Updated Approval Of Its Fast-Acting Erectile Dysfunction Pill - Business Insider
Wed, 24 Jul 2013
Notable Two Hundred Day Moving Average Cross - VVUS - Forbes
Fri, 08 Mar 2013
Pre-market Movers For Feb 1 (XOM, MRK, MAT, LM, DELL, PRGO, TDW, VVUS) - RTTNews
Mon, 06 Aug 2012
How To Make Money From FDA Approval Events - Seeking Alpha
Fri, 24 Feb 2012
VIVUS Inc. (VVUS) Leaped To A New High On FDA Panel Recommendation - RTTNews
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |